GSK plc (NYSE:GSK) ranks among the best undervalued European stocks to buy now. On February 4, GSK plc (NYSE:GSK) announced fourth-quarter earnings that outperformed analyst estimates in several ...

GSK plc's ( LON:GSK ) strong earnings report was rewarded with a positive stock price move. We did some digging ...

Spero Therapeutics’ oral antibiotic tebipenem shows Phase 3 success and supports GSK’s NDA resubmission. Click here to read ...

Shares of GSK PLC GSK dropped 1.77% to £21.59 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.16% to 10,386.23. GSK PLC ...

Considering the limited upside from current levels, the brokerage reiterates its Neutral stance on GSK Pharma.

GSK's Nucala (mepolizumab) has received European Commission approval as an add on maintenance treatment for uncontrolled COPD. The approval is supported by positive Phase III MATINEE trial results.

Analysts at JP Morgan raised their target price on drugmaker GSK to £22.50 on Monday on improving investor perception.

Harvey Jones shows how investors can build a second income stream from a portfolio of UK dividend stocks, entirely tax-free ...

US firm held talks with LSEG to push performance at time of reduced listings and AI concerns ...

Moderna stock is rated Sell amid FDA setbacks for mRNA-1010, commoditized COVID/RSV sales, and cash burn. Read the analysis ...

GlaxoSmithKline Pharmaceuticals achieved a 29% increase in its consolidated profit during the third quarter of 2025, reaching Rs 296 crore. Revenue also rose to Rs 1,041 crore. The company's success ...

Gift Nifty was trading around 25,918 level, a premium of nearly 183 points from the Nifty futures' previous close, indicating a gap-up start for the Indian stock market indices.